AstraZeneca PLC (AZN.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 03:03PM BST. Market open.
| Previous close | 10,862.00 |
| Open | 10,946.00 |
| Bid | 10,910.00 x 0 |
| Ask | 10,914.00 x 0 |
| Day's range | 10,858.00 - 11,018.00 |
| 52-week range | 9,461.00 - 12,348.00 |
| Volume | |
| Avg. volume | 2,898,752 |
| Market cap | 169.161B |
| Beta (5Y monthly) | 0.19 |
| PE ratio (TTM) | 35.66 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.28 (2.10%) |
| Ex-dividend date | 22 Feb 2024 |
| 1y target est | N/A |
- Fool.co.uk
I don’t care how much FTSE bosses are paid as long as they make me rich!
Facing accusations of greed, the pay packages of FTSE CEOs are back in the headlines. But our writer takes a more relaxed view, on one condition. The post I don’t care how much FTSE bosses are paid as long as they make me rich! appeared first on The Motley Fool UK.
- Zacks
AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids
The FDA approves AstraZeneca's (AZN) Fasenra as an add-on maintenance treatment for patients with severe asthma aged six to 11 years.
- Zacks
Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
J&J (JNJ) is set to buy Shockwave Medical (SWAV). FDA approves AstraZeneca's (AZN) Enhertu for metastatic HER2-positive solid tumors.
© 2024 Yahoo. All rights reserved.